J. Kanter Stacy's most recent trade in Applied Therapeutics Inc was a trade of 200,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2026 | 200,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | 03 Feb 2026 | 42,500 | 0 (0%) | 0% | - | Common Stock | ||
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2026 | 22,500 | 42,500 (0%) | 0% | - | Common Stock | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2026 | 20,460 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2026 | 16,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2026 | 16,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Feb 2026 | 10,230 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale of securities on an exchange or to another person at price $ 0.11 per share. | 16 Dec 2025 | 43,000 | 65,000 (0%) | 0% | 0.1 | 4,816 | Common Stock |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Oppenheimer Holdings Inc (Class A) | Stacy J. Kanter | Director | Other type of transaction at price $ 0.00 per share. | 30 Jan 2025 | 1,500 | 4,500 (0%) | 0% | - | Class A non-voting common stock | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 108,000 (0%) | 0% | 0 | Common Stock | |
| Oppenheimer Holdings Inc (Class A) | J. Kanter Stacy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 3,000 | 3,000 (0%) | 0% | - | Class A non-voting common stock | |
| Applied Therapeutics Inc | Kanter Stacy J. | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 01 Dec 2023 | 30,000 | 63,000 (0%) | 0% | 2.2 | 65,367 | Common Stock |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 33,000 (0%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) |